Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VTRS · against 588 other Healthcare companies listed in US-listed
Ranked #173 of 589 · scores higher than 70% of peers
Bars: peers in each 10-point band of the valuation score57 peers with a valuation score of 50–59, including VTRS · Click a bar to see the companies
A mix: stronger free cash flow yield and EBITDA yield, but weaker earnings yield than most Healthcare peers.
| Metric | VTRS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | -2.0% | -4.3% | 57% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 12.7% | -0.8% | 91% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 8.3% | -2.3% | 92% | 20% | |
| Book yieldHigher is better · 587 reported | 66.5% | 25.9% | 82% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 173 | 457M USD | 52 | 58 | |
| 173 | 10.0B USD | 52 | 43 | |
| 173 | 1.4B USD | 52 | 53 | |
| 173 | 374M USD | 52 | 66 | |
| 173 | 21.7B USD | 52 | 32 | |
| 178 | 34.6B USD | 51 | 58 | |
| 178 | 18.5B USD | 51 | 62 | |
| 178 | 34.0B USD | 51 | 49 | |
| 178 | 11.9B USD | 51 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score